Register to view the archived recording here.
Sequenom Aiming to Submit PMA Application to FDA for T21 Test by End of 2012
The company is currently working to "define a clinical study that would be acceptable to the FDA," Sequenom's CEO Harry Hixson said at the Jefferies Global Healthcare conference in New York.
New to GenomeWeb? Register here quickly.